Australia Wound Care Management Medical Equipment Industry Report

Published by: Global Markets Direct

Published: May. 2, 2008 - 341 Pages

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Definitions

2.2.1 Wound Care Management

2.2.1.1 Traditional Wound Management

2.2.1.2 Advanced Wound Management

2.2.1.3 Wound Closure Devices

2.2.1.4 Ostomy

2.2.1.5 Compression Therapy

3 Healthcare Sector Review

3.1 Healthcare Expenditure

3.2 Healthcare Infrastructure

3.3 Healthcare Policy

4 Wound Care Management in Australia

4.1 Wound Care Management Overall Revenues (2000-2012)

4.2 Wound Care Management Overall Volume (2000-2012)

4.3 Wound Care Management Overall Company Shares (2005-2006)

5 Wound Closure Devices in Australia

5.1 Wound Closure Devices Overall Revenues (2000-2012)

5.1.1 Skin Closure Devices Overall Revenues (2000-2012)

5.1.2 Hemostats Overall Revenues (2000-2012)

5.1.3 Tissue Sealants Overall Revenues (2000-2012)

5.2 Wound Closure Devices Overall Volume (2000-2012)

5.2.1 Skin Closure Devices Overall Volume (2000-2012)

5.2.2 Hemostats Overall Volume (2000-2012)

5.2.3 Tissue Sealants Overall Volume (2000-2012)

5.3 Wound Closure Devices Average Price (2000-2012)

5.3.1 Hemostats Average Price (2000-2012)

5.3.2 Tissue Sealants Average Price (2000-2012)

5.3.3 Skin Closure Devices Average Price (2000-2012)

5.4 Wound Closure Devices Distribution Share (2005-2006)

5.5 Wound Closure Devices Company Share (2005-2006)

6 Ostomy in Australia

6.1 Ostomy Overall Revenue (2000-2012)

6.2 Ostomy Overall Volume (2000-2012)

6.3 Ostomy Average Price (2000-2012)

6.4 Ostomy Distribution Share (2005-2006)

6.5 Ostomy Company Share (2005-2006)

7 Advanced Wound Management in Australia

7.1 Advanced Wound Management Overall Revenue (2000-2012)

7.2 Advanced Wound Management Overall Volume (2000-2012)

7.3 Advanced Wound Management Average Price (2000-2012)

7.4 Advanced Wound Management Distribution Share (2005-2006)

7.5 Advanced Wound Management Company Share (2005-2006)

8 Traditional Wound Management in Australia

8.1 Traditional Wound Management Overall Revenue (2000-2012)

8.2 Traditional Wound Management Overall Volume (2000-2012)

8.3 Traditional Wound Management Average Price (2000-2012)

8.4 Traditional Wound Management Distribution Share (2005-2006)

8.5 Traditional Wound Management Company Share (2005-2006)

9 Compression Therapy in Australia

9.1 Compression Therapy Overall Revenue (2000-2012)

9.2 Compression Therapy Overall Volume (2000-2012)

9.3 Compression Therapy Average Price (2000-2012)

9.4 Compression Therapy Distribution Share (2005-2006)

9.5 Compression Therapy Company Share (2005-2006)

10 Covidien Ltd./Tyco Healthcare Company Profile

10.1 Company Overview

10.2 Business Overview

10.2.1 Imaging Solutions

10.2.2 Medical Devices

10.2.3 Medical Supplies

10.2.4 Pharmaceutical Products

10.2.5 Retail Products

10.2.6 Products

10.2.7 History

10.3 Value Chain Analysis

10.3.1 Manufacturing

10.3.2 Product Development

10.3.3 Sales and Marketing

10.4 SWOT Analysis

10.4.1 Covidien Ltd./Tyco Healthcare Strengths

10.4.2 Covidien Ltd./Tyco Healthcare Weaknesses

10.4.3 Covidien Ltd./Tyco Healthcare Opportunities

10.4.4 Covidien Ltd./Tyco Healthcare Threats

10.5 Financial and Operational Review

10.5.1 Financial Statements

10.5.2 Financial Ratios

10.6 Locations And Subsidiaries

10.7 Financial Deals Landscape

10.7.1 Covidien Signs An Agreement With Allergan

10.7.2 Covidien Acquires Scandius Biomedical

10.7.3 Covidien International Finance Completes Private Placement Of $2,750 Million

10.7.4 Covidien And BioSynthema Enter Into Licensing Agreement

10.7.5 Integra LifeSciences Acquires Assets Of Radionics Division From Covidien

10.7.6 Covidien To Sell European Incontinence Business

10.7.7 Covidien To Acquire Tissue Science Laboratories

10.8 Recent Developments

10.8.1 Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007

10.8.2 Mar 18, 2008: Covidien Declares Quarterly Dividend

10.8.3 Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case

10.8.4 Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results

10.8.5 Jan 15, 2008: Covidien Declares Quarterly Dividend

10.8.6 Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results

10.8.7 Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results

10.8.8 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent

10.8.9 Sep 28, 2007: Covidien Declares Quarterly Dividend

10.8.10 Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results

10.9 Covidien Ltd./Tyco Healthcare Pipeline Products

10.9.1 PleuraSeal Lung Sealant System

10.9.1.1 Product Overview

10.9.1.2 Product Description

10.9.1.3 Product Status

10.9.1.4 Product Milestone

10.9.2 Sandman Intro CPAP Device

10.9.2.1 Product Overview

10.9.2.2 Product Description

10.9.2.3 Product Status

10.9.2.4 Product Milestone

11 3M Company Profile

11.1 Company Overview

11.2 Business Overview

11.2.1 Consumer and Office

11.2.2 Display and Graphics

11.2.3 Electro and Communications

11.2.4 Health Care

11.2.5 Industrial and Transportation

11.2.6 Safety, Security and Protection Services

11.2.7 Products

11.3 Value Chain Analysis

11.3.1 Manufacturing

11.3.2 Product Development

11.3.3 Sales and Marketing

11.4 SWOT Analysis

11.4.1 3M Company Strengths

3M Company Weaknesses

3M Company Opportunities

3M Company Threats

11.5 Financial and Operational Review

11.6 Locations And Subsidiaries

11.7 Financial Deals Landscape

11.7.1 3M Canada Acquires Les Entreprises Solumed

11.7.2 3M Acquires Bondo

11.7.3 3M Acquires Lingualcare

11.7.4 3M Acquires Abzil Industria E Comercio

11.7.5 3M Acquires Neo Plast

11.7.6 3M Acquires Assets Of DMS Chile

11.7.7 3M Acquires Business Of Innovative Paper Technologies

11.7.8 3M Acquires Powell

11.7.9 Gen-Probe Signs An Agreement With 3M Company

11.7.10 3M Acquires Acolyte Biomedica

11.7.11 3M Acquires Sealed Air Corp.'S Interest In Polymask Corp.

11.7.12 3M Sells Its Pharmaceutical Business To Meda AB

11.7.13 3M Acquires SoftMed Systems

11.7.14 3M Sells its Pharmaceuticals Business to Graceway

11.7.15 Gen-Probe Signs An Agreement With 3M

11.7.16 3M Sells its Pharmaceutical Operations in the Asia Pacific Region to Ironbridge Capital and Archer Capital

11.7.17 3M Acquires Biotrace International

11.7.18 Ekahau Secures $16 Million In Additional Funding

11.7.19 3M Acquires Brontes Technologies

11.7.20 3M acquires Nylonge Corp

11.7.21 3M Signs An Agreement With ClozeX Medical

11.7.22 3M Acquires OMNII Oral Pharmaceuticals

11.7.23 3M Sells Pharmaceutical Operations In The United States To Graceway

11.7.24 3M Sells Pharmaceutical Business In Europe To Meda AB

11.7.25 3M Sells Pharmaceutical Operations In The Asia Pacific To Ironbridge and Archer Capital

11.7.26 3M Acquires Accuspray Application Technologies Inc.

11.7.27 3M to acquire Rochford Thompson Equipment

11.7.28 3M To Acquire Aearo Technologies From Permira

11.7.29 Permira To Sell Aearo Technologies To 3M

11.8 Recent Developments

11.8.1 Mar 31, 2008: HighJump Software Introduces Survey Management Solution for Direct Store Delivery Businesses

11.8.2 Mar 24, 2008: Brazil's Companhia de Transmissao de Energia Eletrica Paulista Chooses 3M ACCR for Upgrade of Line Over Parana River in Sao Paulo State

11.8.3 Mar 19, 2008: 3M to Headquarter Optical Systems Business in Asia

11.8.4 Mar 19, 2008: 3M To Headquarter Optical Systems Business In North Asia

11.8.5 Feb 11, 2008: 3M Increases Dividend for the 50th Straight Year

11.8.6 Nov 12, 2007: 3M Declares Quarterly Dividend

11.8.7 Oct 24, 2007: 3M And Sanyo Settle Suit On Lithium Ion Battery

11.8.8 Aug 13, 2007: 3M Declares Quarterly Dividend

11.8.9 May 08, 2007: 3M Declares Quarterly Dividend

11.8.10 Apr 30, 2007: Gen-Probe And 3M Collaborate To Develop Rapid Molecular Tests

12 Smith & Nephew Plc Company Profile

12.1 Company Overview

12.2 Business Overview

12.2.1 Advanced Wound Management

12.2.2 Endoscopy

12.2.3 Reconstruction

12.2.4 Trauma and Clinical Therapies

12.2.5 Products

12.2.6 History

12.3 Value Chain Analysis

12.3.1 Manufacturing

12.3.2 Product Development

12.3.3 Sales and Marketing

12.4 SWOT Analysis

12.4.1 Smith & Nephew Plc Strengths

12.4.2 Smith & Nephew Plc Weaknesses

12.4.3 Smith & Nephew Plc Opportunities

12.4.4 Smith & Nephew Plc Threats

12.5 Financial and Operational Review

12.6 Locations And Subsidiaries

12.7 Financial Deals Landscape

12.7.1 Smith & Nephew Endoscopy Sells Its Vascular Business To InaVein

12.7.2 Smith & Nephew Signs An Agreement With Universal Hospital Services

12.7.3 Smith & Nephew Acquires Plus Orthopedics Holding

12.7.4 Smith & Nephew And Teknimed Enter Into Distribution Agreement

12.7.5 Smith & Nephew Acquires BlueSky Medical Group

12.7.6 Smith & Nephew Enters Into An Agreement With Covalon

12.7.7 Smith & Nephew Signs An Agreement With UDL Laboratories

12.7.8 Nexa Orthopedics Signs An Agreement With Smith & Nephew

12.7.9 Smith & Nephew Acquires Osteobiologics

12.7.10 Smith & Nephew And Q-MED Enter Into Licensing Agreement

12.7.11 Smith & Nephew Completes Sale Of 50% Interest In BSN Medical To Montagu Private Equity

12.7.12 ArthroCare Enters Into Licensing Agreement With Smith & Nephew

12.7.13 Smith & Nephew Signs Licensing Agreement With Alexandria Research Technologies

12.7.14 Smith & Nephew Signs An Agreement With ORTHOsoft

12.7.15 Osteotech And Smith & Nephew Enter Into Processing And Distribution Agreement

12.7.16 Smith & Nephew Acquires VERSAJET From HydroCision

12.7.17 Smith & Nephew Terminates Acquisition Of Biomet

12.8 Recent Developments

12.8.1 Apr 02, 2008: Smith & Nephew Declares Second Interim Dividend

12.8.2 Apr 02, 2008: Smith & Nephew Reports 2007 Results

12.8.3 Mar 23, 2008: Smith & Nephew, Corin Battle To Win Over America’s Hip Generation

12.8.4 Feb 29, 2008: Smith & Nephew Appoints SVP, GM

12.8.5 Feb 20, 2008: Smith & Nephew and Synthes Settle Patent Dispute For Trochanteric Fixation Nails

12.8.6 Oct 22, 2007: Smith & Nephew Declares Interim Dividend

12.8.7 May 03, 2007: Smith & Nephew Appoints New CEO

12.9 Smith & Nephew Plc Pipeline Products

12.9.1 R3 Modular resurfacing Acetabular system

12.9.1.1 Product Overview

12.9.1.2 Product Description

12.9.1.3 Product Status

12.9.2 R3 Ceramic-on-ceramic Acetabular System

12.9.2.1 Product Overview

12.9.2.2 Product Description

12.9.2.3 Product Status

13 Baxter International Company Profile

13.1 Company Overview

13.2 Business Overview

13.2.1 BioScience

13.2.2 Medication Delivery

13.2.3 Renal

13.2.4 Products

13.2.5 History

13.3 Value Chain Analysis

13.3.1 Manufacturing

13.3.2 Product Development

13.3.3 Sales and Marketing

13.4 SWOT Analysis

13.4.1 Baxter International Inc. Strengths

13.4.2 Baxter International Inc. Weaknesses

13.4.3 Baxter International Inc. Opportunities

13.4.4 Baxter International Inc. Threats

13.5 Financial and Operational Review

13.6 Locations And Subsidiaries

13.7 Financial Deals Landscape

13.7.1 Baiyunshan And Baxter Form A Joint Venture In China

13.7.2 Baxter Signs Licensing Agreement With Intercytex And Spinal Restoration

13.7.3 Baxter Sells Transfusion Therapies Business to Texas Pacific and Maverick Capital

13.7.4 B. Braun Acquires Renal Therapy Business Of Baxter

13.7.5 Innovata signs a license agreement with Baxter International

Abstract

Australia Wound Care Management Medical Equipment Industry Report

Summary

This report is an essential source for in-depth information and data relating to Australia wound care management medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of thewound care management in Australia

Scope

• The report provides sector information broken down into detailed categories and segments in country.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the industry at a global level, with break downs for the country
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

Get Full Details About This Report >>

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.